Who requires longer-term anticoagulation therapy for venous thromboembolism from the perspective of precision medicine?

Ikeda, Shinya; Yamashita, Yugo; Ono, Koh

Ikeda, Shinya; Yamashita, Yugo; Ono, Koh.

Affiliation

Ikeda S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Yamashita Y; Department of Pharmacology, Shiga University of Medical Science, Shiga 520-2192, Japan.
Ono K; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

Eur Heart J Cardiovasc Pharmacother ; 10(4): 270-271, 2024 Jul 16.

Article in En | MEDLINE | ID: mdl-38688868

Subject(s)

Anticoagulants; Precision Medicine; Venous Thromboembolism; Humans; Venous Thromboembolism/drug therapy; Venous Thromboembolism/diagnosis; Venous Thromboembolism/prevention & control; Anticoagulants/adverse effects; Anticoagulants/therapeutic use; Anticoagulants/administration & dosage; Time Factors; Risk Factors; Treatment Outcome; Drug Administration Schedule; Clinical Decision-Making; Hemorrhage/chemically induced; Risk Assessment; Patient Selection; Blood Coagulation/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Venous Thromboembolism / Precision Medicine / Anticoagulants Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google